Listen Now

Topics Covered

  • Discussion of the Progress in the Treatment of Multiple Myeloma
  • Current Standard of Care, including Clinical Trial Updates
  • New Treatment Approaches
  • The Role of Transplantation
  • Preventing & Managing Treatment Side Effects, Symptoms, Discomfort & Pain
  • Reducing Complications of Bone Disease
  • Talking with Your Treatment Team about Quality-of-Life Concerns
  • The Increasing Role of Telehealth/Telemedicine Appointment, in the Context of COVID-19
  • Lifestyle, Physical Activity & Balance Concerns, with Practical Tips & Guidelines
  • Roadmap to prepare for Telehealth/Telemedicine Appointments, including Technology, List of Questions, Follow-Up Care & Discussion of OpenNotes
  • Questions for Our Panel of Experts

Our Panel of Experts

Matthew J. Butler, MD

Assistant Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, Mays MD Anderson Cancer Center, UT Health San Antonio

Andrew J. Yee, MD

Instructor in Medicine, Harvard Medical School, Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center

Elizabeth K. O’Donnell, MD

Director of Lifestyle Medicine, Massachusetts General Hospital, Associate Director, Mass General Cancer Center’s Survivorship Program, Medical Oncologist, Multiple Myeloma Center, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(85.2 KB)

Workshop Date

This workshop was originally recorded on January 20, 2022.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.